Makris Anastasios, Seferou Maria, Papadopoulos Dimitris P
European Excellent Center of Hypertension, Laiko University Hospital, 24 Agiou Ioannou Theologou Street, 155-61 Athens, Greece.
Int J Hypertens. 2010 Dec 26;2011:598694. doi: 10.4061/2011/598694.
Resistant hypertension is defined as blood pressure above the patient's goal despite the use of 3 or more antihypertensive agents from different classes at optimal doses, one of which should ideally be a diuretic. Evaluation of patients with resistive hypertension should first confirm that they have true resistant hypertension by ruling out or correcting factors associated with pseudoresistance such as white coat hypertension, suboptimal blood pressure measurement technique, poor adherence to prescribed medication, suboptimal dosing of antihypertensive agents or inappropriate combinations, the white coat effect, and clinical inertia. Management includes lifestyle and dietary modification, elimination of medications contributing to resistance, and evaluation of potential secondary causes of hypertension. Pharmacological treatment should be tailored to the patient's profile and focus on the causative pathway of resistance. Patients with uncontrolled hypertension despite receiving an optimal therapy are candidates for newer interventional therapies such as carotid baroreceptor stimulation and renal denervation.
顽固性高血压的定义为,尽管已使用3种或更多不同种类的降压药物且剂量达到最佳,其中理想的一种应为利尿剂,但患者血压仍高于目标值。对顽固性高血压患者进行评估时,应首先通过排除或纠正与假性耐药相关的因素(如白大衣高血压、血压测量技术欠佳、对规定药物依从性差、降压药物剂量欠佳或组合不当、白大衣效应及临床惰性)来确认患者是否患有真正的顽固性高血压。治疗措施包括生活方式和饮食调整、停用导致耐药的药物以及评估高血压的潜在继发原因。药物治疗应根据患者情况量身定制,并聚焦于耐药的致病途径。尽管接受了最佳治疗但血压仍未得到控制的患者,可考虑采用更新的介入治疗方法,如颈动脉压力感受器刺激术和肾去神经术。